nFUSZmywallet, since you requested a naysayer/negative response... If the two GRAS-listed, Cachexia OTC Compounds were any good, then GSK or Bayer would already have them and it will be difficult and very expensive to market these compounds, so future profits on them will take a long time. At some point, way in the future, maybe patients will benefit and profits will increase.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.